Published in Am J Respir Crit Care Med on April 12, 2007
Pulmonary Gas Exchange Response to Indacaterol in COPD | NCT02547558
Mechanisms of hypoxemia. Lung India (2017) 2.01
Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD. Eur J Appl Physiol (2010) 0.82
Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol (2009) 0.80
Are beta2-agonists safe in patients with acute exacerbations of COPD? Am J Respir Crit Care Med (2007) 0.75
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet (2009) 5.51
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med (2009) 2.70
Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 2.45
Health changes in fishermen 2 years after clean-up of the Prestige oil spill. Ann Intern Med (2010) 2.36
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med (2005) 2.09
Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed (2006) 1.89
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology (2006) 1.66
Safety of long-acting beta-agonists in stable COPD: a systematic review. Chest (2008) 1.65
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J (2013) 1.57
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat (2006) 1.53
[Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires]. Med Clin (Barc) (2007) 1.48
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration (2006) 1.47
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension. Liver Transpl (2007) 1.44
Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.41
[Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy]. Arch Bronconeumol (2010) 1.39
Pulmonary vascular involvement in COPD. Chest (2008) 1.38
Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985) (2009) 1.38
Physical activity and clinical and functional status in COPD. Chest (2009) 1.34
Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med (2007) 1.33
Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med (2010) 1.32
Short-term changes in respiratory biomarkers after swimming in a chlorinated pool. Environ Health Perspect (2010) 1.30
Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2005) 1.25
Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J (2012) 1.23
Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol (2011) 1.21
Varicose vein surgery: stripping versus the CHIVA method: a randomized controlled trial. Ann Surg (2010) 1.14
The role of external and matrix pH in mitochondrial reactive oxygen species generation. J Biol Chem (2008) 1.13
Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc (2011) 1.13
A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol (2011) 1.13
[Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]. Arch Bronconeumol (2008) 1.12
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
Prolonged respiratory symptoms in clean-up workers of the prestige oil spill. Am J Respir Crit Care Med (2007) 1.11
Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation. Am J Pathol (2004) 1.10
Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia. PLoS Comput Biol (2009) 1.10
Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet (2010) 1.08
Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J (2012) 1.05
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology (2004) 1.04
Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol (2011) 1.01
Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest (2013) 1.00
Telemedicine enhances quality of forced spirometry in primary care. Eur Respir J (2011) 0.99
The SERPINE2 gene and chronic obstructive pulmonary disease. Am J Hum Genet (2006) 0.99
Similar gene expression profiles in smokers and patients with moderate COPD. Pulm Pharmacol Ther (2010) 0.98
Clinical Decision Support Systems (CDSS) for preventive management of COPD patients. J Transl Med (2014) 0.96
The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research. J Transl Med (2014) 0.95
Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig. Respir Res (2009) 0.95
Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med (2009) 0.95
Synergy-COPD: a systems approach for understanding and managing chronic diseases. J Transl Med (2014) 0.94
Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab (2003) 0.94
The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study. BMC Med Genet (2011) 0.93
Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med (2011) 0.92
Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil (2009) 0.92
Compartmentation of glycogen metabolism revealed from 13C isotopologue distributions. BMC Syst Biol (2011) 0.92
Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985) (2013) 0.91
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med (2010) 0.91
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension. Liver Transpl (2010) 0.91
Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J (2012) 0.90
Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study. Respir Med (2004) 0.89
Modeling of spatial metabolite distributions in the cardiac sarcomere. Biophys J (2007) 0.89
Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest (2005) 0.88
Network medicine analysis of COPD multimorbidities. Respir Res (2014) 0.87
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension. Respir Med (2004) 0.87
[Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients]. Arch Bronconeumol (2011) 0.87
The impact of home hospitalization on healthcare costs of exacerbations in COPD patients. Eur J Health Econ (2007) 0.87
Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure. Am J Kidney Dis (2002) 0.86
Should alternatives to conventional hospitalisation be promoted in an era of financial constraint? Eur J Clin Invest (2013) 0.86
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation (2013) 0.86
Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med (2005) 0.85
Systems Medicine: from molecular features and models to the clinic in COPD. J Transl Med (2014) 0.84
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation. World J Gastroenterol (2006) 0.83
Biomedical research in a Digital Health Framework. J Transl Med (2014) 0.83
Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis. J Appl Physiol (1985) (2010) 0.83
Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD. J Nutr Biochem (2011) 0.83
Workforce preparation: the Biohealth computing model for Master and PhD students. J Transl Med (2014) 0.82
Hospital admissions and exercise capacity decline in patients with COPD. Eur Respir J (2014) 0.82
Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma. J Appl Physiol (1985) (2008) 0.82
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des (2014) 0.82
Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant. J Heart Lung Transplant (2013) 0.82
Expression of BK(Ca) channels in human pulmonary arteries: relationship with remodeling and hypoxic pulmonary vasoconstriction. Vascul Pharmacol (2008) 0.81
Clinical decision support system to enhance quality control of spirometry using information and communication technologies. JMIR Med Inform (2014) 0.81
Plasticity of CD133+ cells: role in pulmonary vascular remodeling. Cardiovasc Res (2007) 0.81